Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-041519
Filing Date
2025-05-09
Accepted
2025-05-09 16:06:14
Documents
55
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0241329-10q_silopharma.htm   iXBRL 10-Q 592387
2 CERTIFICATION ea024132901ex31-1_silopharma.htm EX-31.1 12050
3 CERTIFICATION ea024132901ex31-2_silopharma.htm EX-31.2 11566
4 CERTIFICATION ea024132901ex32-1_silopharma.htm EX-32.1 4683
5 CERTIFICATION ea024132901ex32-2_silopharma.htm EX-32.2 4420
  Complete submission text file 0001213900-25-041519.txt   4617031

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE silo-20250331.xsd EX-101.SCH 44032
7 XBRL CALCULATION FILE silo-20250331_cal.xml EX-101.CAL 29403
8 XBRL DEFINITION FILE silo-20250331_def.xml EX-101.DEF 211488
9 XBRL LABEL FILE silo-20250331_lab.xml EX-101.LAB 420764
10 XBRL PRESENTATION FILE silo-20250331_pre.xml EX-101.PRE 226245
57 EXTRACTED XBRL INSTANCE DOCUMENT ea0241329-10q_silopharma_htm.xml XML 389938
Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236
Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

EIN.: 462137136 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41512 | Film No.: 25930386
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)